Total Holdings
90
Portfolio diversification across 90 positions
SBIO
(NYSEARCA)ALPS Medical Breakthroughs ETF
$50.40-- (--)
Loading... - Market loading
SBIO ETF Holdings: ALPS Medical Breakthroughs ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$141.53M
Total fund assets
Expense Ratio
0.50%
Annual management fee
Fund Issuer
SS&C
NYSEARCA
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 50 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Avidity Biosciences Inc | Stock | 4.67% |
| 2 |  | Kymera Therapeutics, Inc. | Stock | 4.03% |
| 3 |  | Alkermes plc | Stock | 3.73% |
| 4 |  | Arrowhead Pharmaceuticals, Inc | Stock | 3.49% |
| 5 |  | Mirum Pharmaceuticals, Inc. | Stock | 3.39% |
| 6 |  | Cytokinetics, Incorporated | Stock | 3.32% |
| 7 |  | Celcuity Inc. | Stock | 3.24% |
| 8 |  | Axsome Therapeutics, Inc | Stock | 3.21% |
| 9 | M MRUS | Merus BV | Stock | 3.13% |
| 10 |  | Rhythm Pharmaceuticals, Inc | Stock | 3.09% |
| 11 |  | Nuvalent Inc | Stock | 2.99% |
| 12 |  | Structure Therapeutics Inc. | Stock | 2.99% |
| 13 |  | Amicus Therapeutics, Inc. | Stock | 2.96% |
| 14 |  | Crinetics Pharmaceuticals, Inc. | Stock | 2.86% |
| 15 |  | PTC Therapeutics, Inc | Stock | 2.68% |
| 16 |  | ACADIA Pharmaceuticals Inc. | Stock | 2.67% |
| 17 |  | CG Oncology, Inc. | Stock | 2.67% |
| 18 |  | Krystal Biotech, Inc | Stock | 2.66% |
| 19 |  | Vaxcyte, Inc | Stock | 2.52% |
| 20 |  | NewAmsterdam Pharma Company N.V. | Stock | 2.45% |
| 21 |  | Apogee Therapeutics, Inc. | Stock | 2.29% |
| 22 |  | Protagonist Therapeutics Inc | Stock | 2.29% |
| 23 |  | Xenon Pharmaceuticals Inc. | Stock | 2.10% |
| 24 |  | Viking Therapeutics, Inc. | Stock | 2.00% |
| 25 |  | Disc Medicine, Inc. | Stock | 1.99% |
| 26 |  | Denali Therapeutics Inc. | Stock | 1.98% |
| 27 |  | Edgewise Therapeutics, Inc. | Stock | 1.94% |
| 28 |  | Apellis Pharmaceuticals, Inc. | Stock | 1.92% |
| 29 | A AKRO | Akero Therapeutics, Inc | Stock | 1.88% |
| 30 |  | IDEAYA Biosciences, Inc. | Stock | 1.87% |
| 31 |  | Tarsus Pharmaceuticals, Inc. | Stock | 1.77% |
| 32 |  | Travere Therapeutics, Inc. | Stock | 1.77% |
| 33 |  | Vera Therapeutics, Inc. | Stock | 1.76% |
| 34 |  | Praxis Precision Medicines, Inc | Stock | 1.73% |
| 35 |  | Spyre Therapeutics, Inc. | Stock | 1.72% |
| 36 |  | Arcellx Inc | Stock | 1.60% |
| 37 |  | Mineralys Therapeutics, Inc. | Stock | 1.50% |
| 38 |  | Galapagos NV | Stock | 1.47% |
| 39 |  | Maze Therapeutics, Inc. | Stock | 1.42% |
| 40 |  | Arcus Biosciences, Inc | Stock | 1.24% |
| 41 |  | Nuvation Bio Inc | Stock | 1.14% |
| 42 |  | Viridian Therapeutics Inc | Stock | 1.12% |
| 43 |  | Terns Pharmaceuticals Inc | Stock | 1.02% |
| 44 |  | Zai Lab Limited | Stock | 0.95% |
| 45 |  | Olema Pharmaceuticals Inc | Stock | 0.82% |
| 46 |  | Immunocore Holdings plc | Stock | 0.81% |
| 47 |  | Vericel Corporation | Stock | 0.79% |
| 48 |  | MannKind Corp | Stock | 0.79% |
| 49 |  | Celldex Therapeutics Inc | Stock | 0.79% |
| 50 |  | Trevi Therapeutics Inc | Stock | 0.72% |